The National Institutes of Health (NIH) recently awarded the first year of funding from a four-year, $1.3 million grant to the Los Angeles Biomedical Research Institute (LA BioMed) to aid in the research and development of a vaccine to protect patients from the healthcare-related infections, Candida and methicillin-resistant Staphylococcus aureus (MRSA).
The National Institute of Allergy and Infectious Diseases (NIAID) of the NIH awarded the grant to LA BioMed infectious disease specialists John E. Edwards, MD, and Ashraf S. Ibrahim, PhD, to fund the collection and study of samples of patients already enrolled in an ongoing clinical trial to assess the efficacy of the vaccine to protect them from Candida. The researchers will use the samples for a study seeking to determine how the vaccine is working.
"The development of a vaccine to protect people from these healthcare-related infections will be a major step forward in improving the health of people here in the U.S. and around the globe," says David I. Meyer, PhD, LA BioMed president and CEO. "LA BioMed's infectious disease specialists are creating a new generation of vaccines to combat these infections. Securing federal funding for such important studies is critical to advancing innovations and developing the medical breakthroughs needed to protect patient health."
Candida is the fourth leading cause of bloodstream infections among hospital patients in the U.S. It is a fungus that commonly lives on the skin, in mucous membranes, like the nose, and in the intestine. When a person's immune system is compromised, Candida can reproduce too quickly, or it can be introduced into a patient's body through a medical device, such as a main line, and cause a bloodstream infection.
MRSA is a strain of staph bacteria that has become resistant to the antibiotics commonly used to treat ordinary staph infections. MRSA infections are more likely to occur in hospitals and other healthcare settings, such as nursing homes and dialysis centers.
The research will be supported by NIAID Grant No. R01AI063382.
Source: LA BioMed
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.